This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Small-Cap Winners & Losers

The small-cap sector traded beneath the major indices Thursday even as several names soared on various positive news.

Volt Information Sciences (VOL), for instance, leapt 25.8% after the New York-based staffing company posted fiscal third-quarter income of $9.1 million, or 40 cents a share. That crushes two analysts' 32-cent EPS estimate, per Thomson Financial. Shares were up $3.95 to $19.24.

In positive analyst calls, meanwhile, California's Conexant Systems (CNXT) surged 17.5% to $1.34 after CIBC upped the semiconductor concern to sector outperformer, citing stock valuation and his belief that "real restructuring" seems to be on the horizon. He pointed to yesterday's announcement that Karen Roscher will replace J. Scott Blouin as chief financial officer, which follows Daniel Artusi's appointment as CEO earlier this year.

Elsewhere, Provectus Pharmaceuticals (PVCT) jumped 16.2% in very heavy trading after getting clearance for midphase testing on Provecta, which is proposed to treat stage III and IV metastatic melanoma -- an advanced form of skin cancer. Shares of the Knoxville, Tenn., company were up 39 cents to $2.80.

Natural-gas processor MarkWest Hydrocarbon (MWP) was also well in positive territory after agreeing to merge with MarkWest Energy Partners (MWE), which the former currently controls and operates. MarkWest Hydrocarbon investors will receive around $734 million in stock and cash, or $61.12 a share, and the company will become a wholly owned subsidiary of MarkWest Energy.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CNXT $30.10 0.50%
MWE $0.00 0.00%
PVCT $0.46 3.17%
AAPL $94.27 -0.76%
FB $101.00 1.47%


Chart of I:DJI
DOW 15,914.74 -99.64 -0.62%
S&P 500 1,851.86 -0.35 -0.02%
NASDAQ 4,283.5920 +14.8290 0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs